Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis.

[1]  S. Carozzi,et al.  Peritoneal Dialysis Solution pH and Ca2+ Concentration Regulate Peritoneal Macrophage and Mesothelial Cell Activation , 1994, ASAIO journal.

[2]  T. Weinreich,et al.  Transperitoneal Calcium Mass Transfer using Dialv Sate with a Low Calcium Concentration (1.0 mM) , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[4]  A. Hutchison,et al.  Effect of Long Term Therapy with 1.25 Mmol/L Calcium Peritoneal Dialysis Fluid on the Incidence of Peritonitis in Capd , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  B. Piraino,et al.  Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  J. Holley,et al.  The Use of Dialysate Containing 2.5 Meq/L Calcium in Peritoneal Dialysis Patients , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  J. Cunningham,et al.  Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  R. Gokal,et al.  Low Calcium Dialysate with Oral Caco3 in Capd , 1991 .

[9]  H. Kawanishi,et al.  Clinical application of low calcium peritoneal dialysate. , 1991, ASAIO transactions.

[10]  S. Barocci,et al.  Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patients. , 1990, ASAIO transactions.

[11]  H. Verbrugh,et al.  Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  S. Scully,et al.  Calcium exchange and ionized cytoplasmic calcium in resting and activated human monocytes. , 1984, The Journal of clinical investigation.

[13]  T. Takenawa,et al.  The mechanism of macrophage activation induced by Ca2+ ionophore. , 1983, Cellular immunology.

[14]  R Y Tsien,et al.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator , 1982, The Journal of cell biology.

[15]  H. Verbrugh,et al.  Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. , 1982, The Journal of clinical investigation.

[16]  R. Gokal.  Renal Osteodystrophy in Continuous Ambulatory Peritoneal Dialysis , 1981 .

[17]  P. Peterson,et al.  Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. , 1981, The Journal of infectious diseases.

[18]  H. Verbrugh,et al.  Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. , 1978, Journal of clinical pathology.

[19]  J. Verhoef,et al.  Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. , 1977, The Journal of infectious diseases.